- Home
- OMCL vs BMEZ Comparison
OMCL vs BMEZ Comparison
Compare OMCL & BMEZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCL
- BMEZ
- Stock Information
- Founded
- OMCL 1992
- BMEZ N/A
- Country
- OMCL United States
- BMEZ United States
- Employees
- OMCL N/A
- BMEZ N/A
- Industry
- OMCL Computer Manufacturing
- BMEZ Trusts Except Educational Religious and Charitable
- Sector
- OMCL Technology
- BMEZ Finance
- Exchange
- OMCL Nasdaq
- BMEZ Nasdaq
- Market Cap
- OMCL 1.5B
- BMEZ 1.5B
- IPO Year
- OMCL 2001
- BMEZ N/A
- Fundamental
- Price
- OMCL $25.39
- BMEZ $14.28
- Analyst Decision
- OMCL Buy
- BMEZ
- Analyst Count
- OMCL 6
- BMEZ 0
- Target Price
- OMCL $45.83
- BMEZ N/A
- AVG Volume (30 Days)
- OMCL 727.0K
- BMEZ 391.3K
- Earning Date
- OMCL 05-06-2025
- BMEZ 01-01-0001
- Dividend Yield
- OMCL N/A
- BMEZ 8.71%
- EPS Growth
- OMCL N/A
- BMEZ N/A
- EPS
- OMCL 0.45
- BMEZ 0.54
- Revenue
- OMCL $1,135,755,000.00
- BMEZ N/A
- Revenue This Year
- OMCL $3.75
- BMEZ N/A
- Revenue Next Year
- OMCL $4.42
- BMEZ N/A
- P/E Ratio
- OMCL $56.43
- BMEZ $30.17
- Revenue Growth
- OMCL 3.00
- BMEZ N/A
- 52 Week Low
- OMCL $22.66
- BMEZ $12.93
- 52 Week High
- OMCL $55.75
- BMEZ $16.95
- Technical
- Relative Strength Index (RSI)
- OMCL 26.13
- BMEZ 49.20
- Support Level
- OMCL $22.66
- BMEZ $14.06
- Resistance Level
- OMCL $32.18
- BMEZ $14.89
- Average True Range (ATR)
- OMCL 1.18
- BMEZ 0.29
- MACD
- OMCL -0.46
- BMEZ 0.07
- Stochastic Oscillator
- OMCL 28.68
- BMEZ 59.06
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
About BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.